Glenmark Life Sciences Limited (IN:ALIVUS)
:ALIVUS
Want to see IN:ALIVUS full AI Analyst Report?
Summary of all the Indicators
Overall Consensus
Strong Buy
16Bullish
5Neutral
1Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Glenmark Life Sciences Limited’s (ALIVUS) Moving Averages Convergence Divergence (MACD) indicator is -4.85, suggesting Glenmark Life Sciences Limited is a Buy.
Glenmark Life Sciences Limited’s (ALIVUS) 20-Day exponential moving average is 1044.25, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Buy.
Glenmark Life Sciences Limited’s (ALIVUS) 50-Day exponential moving average is 1034.57, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Buy.
Glenmark Life Sciences Limited (ALIVUS) Pivot Points
Classic
967.35
996.15
1,021.55
1,050.35
1,075.75
1,104.55
1,129.95
Fibonacci
996.15
1,016.85
1,029.65
1,050.35
1,071.05
1,083.85
1,104.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Glenmark Life Sciences Limited (ALIVUS) Moving Averages
MA5
1,037.03Buy
1,039.64Buy
MA10
1,033.67Buy
1,039.11Buy
MA20
1,045.81Buy
1,044.25Buy
MA50
1,052.64Sell
1,034.57Buy
MA100
986.95Buy
1,006.15Buy
MA200
953.57Buy
982.18Buy
Glenmark Life Sciences Limited’s (ALIVUS) 10-Day exponential moving average is 1039.11, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Buy.
Glenmark Life Sciences Limited’s (ALIVUS) 100-Day exponential moving average is 1006.15, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Buy.
Glenmark Life Sciences Limited’s (ALIVUS) stock price is ₹920.8 and Glenmark Life Sciences Limited’s (ALIVUS) 50-day simple moving average is 1052.64, creating a Sell signal.
Glenmark Life Sciences Limited’s (ALIVUS) stock price is ₹920.8 and Glenmark Life Sciences Limited’s (ALIVUS) 100-day simple moving average is 986.95, creating a Buy signal.
Glenmark Life Sciences Limited’s (ALIVUS) stock price is ₹920.8 and Glenmark Life Sciences Limited’s (ALIVUS) 200-day simple moving average is 953.57, creating a Buy signal.
Glenmark Life Sciences Limited (ALIVUS) Technical Indicators
RSI (14)
51.84
Neutral
STOCH (9,6)
51.95
Neutral
STOCHRSI (14)
34.74
Neutral
MACD (12,26)
-4.85
Buy
ADX (14)
13.09
Buy
Williams %R
-56.28
Buy
CCI (14)
27.26
Neutral
ATR (14)
37.46
-
Ultimate Oscillator
35.68
Neutral
ROC
0.34
Buy
Glenmark Life Sciences Limited’s (ALIVUS) Relative Strength Index (RSI) is 51.84, creating a Neutral signal.
Glenmark Life Sciences Limited’s (ALIVUS) Trend Strength Indicator (ADX) is 13.09, creating a Buy signal.
Glenmark Life Sciences Limited’s (ALIVUS) Commodity Channel Index (CCI) is 27.26, creating a Neutral signal.
Glenmark Life Sciences Limited’s (ALIVUS) Price Rate of Change (ROC) is 0.34, creating a Buy signal.
FAQ
Is ALIVUS a Buy, Hold, or Sell?
Based on ALIVUS’s technical indicators, ALIVUS is a Strong Buy.
What is ALIVUS’s RSI (14)?
ALIVUS’s RSI (14) is 51.84, which suggests ALIVUS is a Neutral.
What is ALIVUS’s MACD?
ALIVUS’s MACD is -4.85, which suggests ALIVUS is a Buy.
What is ALIVUS’s 5-day moving average?
ALIVUS’s 5-day moving average is 1037.03, which suggests ALIVUS is a Buy.
What is ALIVUS’s 20-day moving average?
ALIVUS 20-day moving average is 1045.81, which suggests ALIVUS is a Buy.
What is ALIVUS’s 50-day moving average?
ALIVUS’s 50-day moving average is 1052.64, which suggests ALIVUS is a Sell.
What is ALIVUS’s 200-day moving average?
ALIVUS’s 200-day moving average is 953.57, which suggests ALIVUS is a Buy.
What is ALIVUS’s Williams % R (14)?
ALIVUS’s Williams % R (14) is -56.28, which suggests ALIVUS is a Buy.
What is ALIVUS’s CCI (14)?
ALIVUS’s CCI (14) is 27.26, which suggests ALIVUS is a Neutral.
What is the share price of Glenmark Life Sciences Limited?